National Institute for Health and Care Excellence.
non-departmental public body of the Department of Health in the United Kingdom
- Reports this week
- 1
- Active events
- 2
- Connections
- 40
What's happening
Active this week
Earlier this month
-
NICE encourages NHS Trusts in England to report risks due to the ongoing staffing crisis and patient safety issues.Some support1 report1 development inside
-
A study using data from the Our Future Health programme and guidelines applied in England's primary care.Some support1 report1 development inside
-
Official guidance informed by the NIHC is being used in both England and Scotland to gather testimonies regarding ME/CFS treatment.Some support1 report
One to three months ago
-
Prostate Cancer UK urged the National Institute for Health and Care Excellence (NICE) to review evidence regarding focal therapy for prostate cancer.Some support7 reports
-
NICE recommends routine NHS funding for advanced perfusion devices following successful FDA De Novo clearance.Some support3 reports
-
NICE recommended ALK-Abelló's allergy tablets, which are now available through the National Health Service.Some support1 report
-
The National Institute for Health and Care Excellence and the Institute of Cancer Research reviewed guidelines based on joint research findings.Some support1 report
Gone quiet
No new reports in 90+ days-
John Edwards pioneered treatment for rib fractures in Sheffield, gaining recognition from the Chest Wall Injury Society.Some support1 report
-
Wegovy's availability within the UK National Health Service is currently dependent on a review conducted by the National Institute for Health and Care Excellence (NICE).Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching National Institute for Health and Care Excellence
Events traced to National Institute for Health and Care Excellence, step by step, newest firstAround National Institute for Health and Care Excellence this week
News at the entities that move National Institute for Health and Care Excellence most-
Imperial College London StructuralImperial College London and Yonam Institute of Technology discussed the impact of AI on entrepreneurship.Moves National Institute for Health and Care Excellence
-
FDA OperationalNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves National Institute for Health and Care Excellence
-
ALK-Abelló StructuralALK-Abelló conducted a Phase 3 clinical trial in China on October 19, 2026.Moves National Institute for Health and Care Excellence
-
England StructuralTembo is conducting an analysis of schemes across 17 English cities, including Brighton and Bristol.Moves National Institute for Health and Care Excellence
-
Eli Lilly and Company StructuralMedicare coverage is driving growth in the obesity drug market, leading to raised price targets for Eli Lilly.Moves National Institute for Health and Care Excellence
-
National Health Service StructuralMatthew Hopkins has been appointed director for acute care of NHS Alliance, with services mandated to be organized across England.Moves National Institute for Health and Care Excellence
Connections
The 15 strongest of 40, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
National Health Service Structural
NICE controls drug spending and recommends funding criteria that the NHS must follow for its operations.
-
National Health Service Structural
NICE evaluates the cost and clinical benefit of drugs, producing recommendations that the NHS must follow for implementation.
-
England Structural
NICE provides formal guidelines and recommendations that govern healthcare standards and resource allocation within England.
-
Eli Lilly and Company Structural
NICE formally evaluates the cost-effectiveness of products like those offered by Eli Lilly to determine market access in the UK.
-
Imperial College London Structural
Imperial College London provides research evidence and reports that inform the National Institute for Health and Care Excellence's treatment reviews.
-
Prostate Cancer UK Operational
Prostate Cancer UK actively influences NICE regarding the review and approval of focal therapy evidence.
-
Institute of Cancer Research Operational
The Institute of Cancer Research's joint research findings are used by NICE when reviewing guidelines.
-
Jonathan Benger Structural
Jonathan Benger serves as the chief executive of the National Institute for Health and Care Excellence.
Show all 15 connections
-
John Edwards Structural
John Edwards' expertise was a key input informing the NICE guidelines regarding rib fractures.
-
Ireland Shared context
NICE operates as a UK body whose decisions and conditions impact the healthcare landscape in Ireland.
-
ALK-Abelló Structural
NICE formally recommended ALK-Abelló's allergy tablets, influencing their market access in the UK.
-
FDA Operational
NICE bases its guidance and confidence on successful clearance achieved by the FDA process.
-
Jake Structural
A's treatment access is subject to formal assessment and gatekeeping by the NICE body.
-
Pharmaceutical Journal Operational
The Pharmaceutical Journal contributes published assessments on cancer treatments and drug pricing to NICE's evaluations.
-
Wales Structural
NICE approves healthcare tests, setting standards that influence the use of medical technology within Wales.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
3 events- NICE encourages NHS Trusts in England to report risks due to the ongoing staffing crisis and patient safety issues.
- A study using data from the Our Future Health programme and guidelines applied in England's primary care.
- Official guidance informed by the NIHC is being used in both England and Scotland to gather testimonies regarding ME/CFS treatment.
August 2026
4 events- Prostate Cancer UK urged the National Institute for Health and Care Excellence (NICE) to review evidence regarding focal therapy for prostate cancer.
- NICE recommends routine NHS funding for advanced perfusion devices following successful FDA De Novo clearance.
- NICE recommended ALK-Abelló's allergy tablets, which are now available through the National Health Service.
- The National Institute for Health and Care Excellence and the Institute of Cancer Research reviewed guidelines based on joint research findings.